Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$0.62 - $1.17 $21,047 - $39,719
-33,948 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$1.09 - $1.89 $62,690 - $108,701
-57,514 Reduced 62.88%
33,948 $37,000
Q3 2021

Nov 01, 2021

BUY
$1.44 - $2.73 $106,483 - $201,875
73,947 Added 422.19%
91,462 $166,000
Q2 2021

Aug 12, 2021

BUY
$2.63 - $3.67 $2,061 - $2,877
784 Added 4.69%
17,515 $46,000
Q1 2021

May 13, 2021

SELL
$2.82 - $5.6 $1.47 Million - $2.92 Million
-521,945 Reduced 96.89%
16,731 $60,000
Q4 2020

Feb 04, 2021

SELL
$2.09 - $3.09 $1.49 Million - $2.2 Million
-711,876 Reduced 56.92%
538,676 $1.36 Million
Q3 2020

Nov 09, 2020

BUY
$2.39 - $3.43 $1.81 Million - $2.6 Million
757,158 Added 153.46%
1,250,552 $3.15 Million
Q2 2020

Jul 20, 2020

BUY
$2.2 - $3.71 $807,774 - $1.36 Million
367,170 Added 290.89%
493,394 $1.62 Million
Q1 2020

Apr 30, 2020

BUY
$1.9 - $4.98 $239,825 - $628,595
126,224 New
126,224 $309,000
Q3 2019

Nov 04, 2019

SELL
$4.13 - $6.94 $1.56 Million - $2.63 Million
-378,669 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$3.98 - $6.2 $1.38 Million - $2.15 Million
346,763 Added 1086.83%
378,669 $2.21 Million
Q1 2019

Apr 29, 2019

BUY
$2.0 - $4.4 $15,012 - $33,026
7,506 Added 30.76%
31,906 $123,000
Q4 2018

Feb 01, 2019

BUY
$1.61 - $3.62 $39,284 - $88,328
24,400 New
24,400 $46,000
Q3 2018

Nov 06, 2018

SELL
$2.26 - $3.27 $28,177 - $40,770
-12,468 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$3.02 - $4.94 $37,653 - $61,591
12,468 New
12,468 $38,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.